These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15064733)

  • 1. Upregulation of macrophage migration inhibitory factor contributes to induced N-Myc expression by the activation of ERK signaling pathway and increased expression of interleukin-8 and VEGF in neuroblastoma.
    Ren Y; Chan HM; Li Z; Lin C; Nicholls J; Chen CF; Lee PY; Lui V; Bacher M; Tam PK
    Oncogene; 2004 May; 23(23):4146-54. PubMed ID: 15064733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer.
    Xu X; Wang B; Ye C; Yao C; Lin Y; Huang X; Zhang Y; Wang S
    Cancer Lett; 2008 Mar; 261(2):147-57. PubMed ID: 18171602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
    Marampon F; Ciccarelli C; Zani BM
    Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage migration inhibitory factor up-regulates alpha(v)beta(3) integrin and vascular endothelial growth factor expression in endometrial adenocarcinoma cell line Ishikawa.
    Bondza PK; Metz CN; Akoum A
    J Reprod Immunol; 2008 Apr; 77(2):142-51. PubMed ID: 17854909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of tumor growth and metastasis in vitro and in vivo by targeting macrophage migration inhibitory factor in human neuroblastoma.
    Ren Y; Chan HM; Fan J; Xie Y; Chen YX; Li W; Jiang GP; Liu Q; Meinhardt A; Tam PK
    Oncogene; 2006 Jun; 25(25):3501-8. PubMed ID: 16449971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage migration inhibitory factor upregulates angiogenic factors and correlates with clinical measures in rheumatoid arthritis.
    Kim HR; Park MK; Cho ML; Yoon CH; Lee SH; Park SH; Leng L; Bucala R; Kang I; Choe J; Kim HY
    J Rheumatol; 2007 May; 34(5):927-36. PubMed ID: 17407222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma.
    Das B; Yeger H; Tsuchida R; Torkin R; Gee MF; Thorner PS; Shibuya M; Malkin D; Baruchel S
    Cancer Res; 2005 Aug; 65(16):7267-75. PubMed ID: 16103078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of N-myc in neuroblastoma by autocrine IGF-II depends on farnesylated Ras. Application of farnesyltransferase inhibitors.
    Wittrock J; Schweizer P; Girgert R
    Anticancer Res; 2002; 22(6C):4205-9. PubMed ID: 12553057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.
    Lue H; Thiele M; Franz J; Dahl E; Speckgens S; Leng L; Fingerle-Rowson G; Bucala R; Lüscher B; Bernhagen J
    Oncogene; 2007 Aug; 26(35):5046-59. PubMed ID: 17310986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage migration inhibitory factor up-regulates the expression of interleukin-8 messenger RNA in synovial fibroblasts of rheumatoid arthritis patients: common transcriptional regulatory mechanism between interleukin-8 and interleukin-1beta.
    Onodera S; Nishihira J; Koyama Y; Majima T; Aoki Y; Ichiyama H; Ishibashi T; Minami A
    Arthritis Rheum; 2004 May; 50(5):1437-47. PubMed ID: 15146413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity.
    Lue H; Kapurniotu A; Fingerle-Rowson G; Roger T; Leng L; Thiele M; Calandra T; Bucala R; Bernhagen J
    Cell Signal; 2006 May; 18(5):688-703. PubMed ID: 16122907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MIF loss impairs Myc-induced lymphomagenesis.
    Talos F; Mena P; Fingerle-Rowson G; Moll U; Petrenko O
    Cell Death Differ; 2005 Oct; 12(10):1319-28. PubMed ID: 15947793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells.
    Xu Z; Maiti D; Kisiel W; Duh EJ
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2819-25. PubMed ID: 17023682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.
    Fan L; Iyer J; Zhu S; Frick KK; Wada RK; Eskenazi AE; Berg PE; Ikegaki N; Kennett RH; Frantz CN
    Cancer Res; 2001 Feb; 61(3):1073-9. PubMed ID: 11221835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung.
    Kamimura A; Kamachi M; Nishihira J; Ogura S; Isobe H; Dosaka-Akita H; Ogata A; Shindoh M; Ohbuchi T; Kawakami Y
    Cancer; 2000 Jul; 89(2):334-41. PubMed ID: 10918163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Myc and Bcl-2 coexpression induces MMP-2 secretion and activation in human neuroblastoma cells.
    Noujaim D; van Golen CM; van Golen KL; Grauman A; Feldman EL
    Oncogene; 2002 Jul; 21(29):4549-57. PubMed ID: 12085233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage migration inhibitory factor: roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma.
    Ren Y; Tsui HT; Poon RT; Ng IO; Li Z; Chen Y; Jiang G; Lau C; Yu WC; Bacher M; Fan ST
    Int J Cancer; 2003 Oct; 107(1):22-9. PubMed ID: 12925952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour necrosis factor-alpha up-regulates macrophage migration inhibitory factor expression in endometrial stromal cells via the nuclear transcription factor NF-kappaB.
    Cao WG; Morin M; Sengers V; Metz C; Roger T; Maheux R; Akoum A
    Hum Reprod; 2006 Feb; 21(2):421-8. PubMed ID: 16210389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-myc oncogene overexpression down-regulates IL-6; evidence that IL-6 inhibits angiogenesis and suppresses neuroblastoma tumor growth.
    Hatzi E; Murphy C; Zoephel A; Rasmussen H; Morbidelli L; Ahorn H; Kunisada K; Tontsch U; Klenk M; Yamauchi-Takihara K; Ziche M; Rofstad EK; Schweigerer L; Fotsis T
    Oncogene; 2002 May; 21(22):3552-61. PubMed ID: 12032857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Myc overexpression leads to decreased beta1 integrin expression and increased apoptosis in human neuroblastoma cells.
    van Golen CM; Soules ME; Grauman AR; Feldman EL
    Oncogene; 2003 May; 22(17):2664-73. PubMed ID: 12730680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.